Biogen and Eisai stocks soar on Alzheimer's success
Shares in Biogen and Eisai soared today reflecting the surprise trial success of their experimental Alzheimer's drug, which also lifted the stocks of rival drugmakers Roche and Eli Lilly.
Business
• 28 Sep 22
